Elevated serum β-synuclein predicts cognitive decline and progression to dementia
Our findings underscore serum β-synuclein as a promising biomarker for AD progression and cognitive decline. Further research is warranted to clarify its role in the pathogenesis of AD and validate its utility in clinical settings.
Authors
- Nayeong Kong (ORCID: https://orcid.org/0000-0002-9095-1701)
- Joon Hyung Jung (ORCID: https://orcid.org/0000-0003-1669-6113)
Institutions
- Chungbuk National University (KR)
- Keimyung University (KR)
Publication Details
- Journal
- Journal of Neurology Neurosurgery & Psychiatry
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1136/jnnp-2025-336234
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00